CareCloud 미래 성장

Future 기준 확인 0/6

CareCloud은 연간 수입과 매출이 각각 104.4%와 1.7% 증가할 것으로 예상되고 EPS는 연간 104.9%만큼 증가할 것으로 예상됩니다.

주요 정보

104.4%

수익 성장률

104.9%

EPS 성장률

Healthcare Services 수익 성장	31.9%
매출 성장률	1.7%
향후 자기자본 수익률	n/a
애널리스트 커버리지	Low
마지막 업데이트	15 Nov 2024

최근 미래 성장 업데이트

Recent updates

CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth

Nov 13

We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt

Oct 07

CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth

Aug 31

CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Jul 13

We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt

Jun 27

CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%

May 22

CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate

Mar 22

The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%

Mar 22

Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding

Feb 02

Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?

Jan 30

CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues

Dec 19

CareCloud, Inc. (NASDAQ:CCLD) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 06

There's Been No Shortage Of Growth Recently For CareCloud's (NASDAQ:CCLD) Returns On Capital

Mar 05

CareCloud (NASDAQ:MTBC) Is Looking To Continue Growing Its Returns On Capital

Aug 20

These 4 Measures Indicate That CareCloud (NASDAQ:MTBC) Is Using Debt Safely

Jul 23

CareCloud (NASDAQ:MTBC) Shareholders Will Want The ROCE Trajectory To Continue

May 12

MTBC Has Dropped A 'Bomb' On MTBCP, Consequently Creating A 'Game-Changer' Event For Both

Jan 28

CareCloud EPS beats by $0.03, beats on revenue

May 06

수익 및 매출 성장 예측

NasdaqGM:CCLD - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	116	-4	N/A	23	2
12/31/2025	111	-4	N/A	26	4
12/31/2024	111	-5	N/A	19	4
9/30/2024	111	-52	12	19	N/A
6/30/2024	112	-58	7	16	N/A
3/31/2024	113	-62	8	19	N/A
12/31/2023	117	-64	4	15	N/A
9/30/2023	121	-20	6	18	N/A
6/30/2023	126	-16	8	20	N/A
3/31/2023	133	-12	7	19	N/A
12/31/2022	139	-10	9	21	N/A
9/30/2022	144	-7	9	21	N/A
6/30/2022	148	-6	8	19	N/A
3/31/2022	145	-9	4	15	N/A
12/31/2021	140	-11	3	13	N/A
9/30/2021	134	-15	1	11	N/A
6/30/2021	128	-18	-5	4	N/A
3/31/2021	113	-23	-4	4	N/A
12/31/2020	105	-23	-9	-1	N/A
9/30/2020	89	-21	-8	-1	N/A
6/30/2020	74	-16	-4	1	N/A
3/31/2020	71	-11	-1	3	N/A
12/31/2019	64	-7	5	8	N/A
9/30/2019	65	-8	5	7	N/A
6/30/2019	65	-9	7	8	N/A
3/31/2019	57	-8	6	7	N/A
12/31/2018	51	-7	6	7	N/A
9/30/2018	42	-6	5	6	N/A
6/30/2018	33	-4	N/A	3	N/A
3/31/2018	32	-5	N/A	2	N/A
12/31/2017	32	-8	N/A	0	N/A
9/30/2017	32	-11	N/A	-2	N/A
6/30/2017	30	-11	N/A	-1	N/A
3/31/2017	28	-10	N/A	-1	N/A
12/31/2016	24	-10	N/A	-1	N/A
9/30/2016	21	-6	N/A	0	N/A
6/30/2016	21	-6	N/A	-1	N/A
3/31/2016	22	-6	N/A	-1	N/A
12/31/2015	23	-5	N/A	-2	N/A
9/30/2015	25	-5	N/A	-3	N/A
6/30/2015	25	-6	N/A	-4	N/A
3/31/2015	22	-5	N/A	-4	N/A
12/31/2014	18	-5	N/A	-3	N/A
9/30/2014	14	-3	N/A	-2	N/A
6/30/2014	11	-1	N/A	1	N/A
3/31/2014	11	-1	N/A	1	N/A
12/31/2013	10	0	N/A	1	N/A

애널리스트 미래 성장 예측

수입 대 저축률: CCLD 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: CCLD 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: CCLD 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: CCLD 의 수익(연간 1.7% ) US 시장( 9.1% 보다 느리게 성장할 것으로 예상됩니다. 9.1% 연간).

고성장 수익: CCLD 의 수익(연간 1.7% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: CCLD 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/20 00:12
장 마감 주가	2024/12/20 00:00
수익	2024/09/30
연간 수익	2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

CareCloud, Inc. 11 애널리스트 중 4 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
William Sutherland	Benchmark Company
Michael Hickey	Benchmark Company
Marc Wiesenberger	B. Riley Securities, Inc.

CareCloud 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

CareCloud, Inc. Reaffirms Earnings Guidance for the Full Year 2024

Consensus EPS estimates upgraded to US$0.037 loss

Price target increased by 7.3% to US$3.68

CareCloud, Inc. Reiterates Revenue Guidance for the Year 2024

Consensus EPS estimates upgraded to US$0.77 loss, revenue downgraded

CareCloud, Inc. Reiterates Revenue Guidance for the Fiscal Year Ending December 31, 2023

Recent updates

CareCloud, Inc. Announces Management Changes, Effective January 1, 2025

CareCloud, Inc. Reaffirms Earnings Guidance for the Full Year 2024

CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth

CareCloud, Inc. to Report Q3, 2024 Results on Nov 12, 2024

We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt

CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth

CareCloud, Inc. to Report Q2, 2024 Results on Aug 13, 2024

CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt

CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%

CareCloud, Inc Promotes Crystal Williams to Chief Operating Officer

Consensus EPS estimates upgraded to US$0.037 loss

Price target increased by 7.3% to US$3.68

CareCloud, Inc. Reiterates Revenue Guidance for the Year 2024

CareCloud, Inc. to Report Q1, 2024 Results on May 14, 2024

CareCloud, Inc., Annual General Meeting, Jun 17, 2024

Consensus EPS estimates upgraded to US$0.77 loss, revenue downgraded

CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate

The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%

Full year 2023 earnings released: US$4.11 loss per share (vs US$0.67 loss in FY 2022)

CareCloud, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding

Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?

CareCloud, Inc. Announces Chief Financial Officer Changes

CareCloud Takes Center Stage at The Arab Health Exhibition and Congress 2024

Founder & Executive Chairman recently bought US$645k worth of stock

CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues

Carecloud, Inc. Appoints Justin Pierce as Its Chief Sales Officer

Independent Director recently bought US$97k worth of stock

CareCloud, Inc. Reiterates Revenue Guidance for the Fiscal Year Ending December 31, 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

CareCloud, Inc. to Report Q3, 2023 Results on Nov 02, 2023

CareCloud, Inc. Appoints Bill Korn as Board of Directors

Is CareCloud (NASDAQ:CCLD) A Risky Investment?

Carecloud, Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023

New minor risk - Share price stability

Consensus revenue estimates fall by 15%

Things Look Grim For CareCloud, Inc. (NASDAQ:CCLD) After Today's Downgrade

Price target decreased by 32% to US$6.28

CareCloud, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues

CareCloud, Inc. to Report Q2, 2023 Results on Aug 03, 2023

CareCloud, Inc. Appoints Larry Steenvoorden as Chief Financial Officer

No longer forecast to breakeven

CareCloud Strengthens Leadership Team with Key Transitions

CareCloud, Inc. (NASDAQ:CCLD) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Carecloud, Inc. Reiterates Revenue Guidance for the Fiscal Year Ending December 31, 2023

There's Been No Shortage Of Growth Recently For CareCloud's (NASDAQ:CCLD) Returns On Capital

Full year 2022 earnings: EPS misses analyst expectations

CareCloud, Inc. to Report Q4, 2022 Results on Mar 02, 2023

CareCloud, Inc. to Unveil Innovative EHR Therapy Platform At American Physical Therapy Association Meeting

CareCloud, Inc. Charts Now Certified for Interoperability According to ONC Standards

CareCloud, Inc. Updates Revenue Guidance for the Year 2022 and 2023

Forecast to breakeven in 2025

Price target decreased to US$8.92

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

CareCloud, Inc. Reiterates Earnings Guidance for the Year 2022

CareCloud, Inc. to Report Q3, 2022 Results on Nov 03, 2022

CareCloud, Inc. Announces the Launch of Its Remote Patient Monitoring Solution

CareCloud, Inc. Deploys Its CareCloud Wellness to Bring Providers Next Generation Chronic Care Management Services

CareCloud (NASDAQ:MTBC) Is Looking To Continue Growing Its Returns On Capital

Consensus EPS estimates fall by 12%

Second quarter 2022 earnings: EPS exceeds analyst expectations

CareCloud, Inc. Provides Revenue Guidance for Full Year 2022

Price target decreased to US$12.58

CareCloud, Inc. to Report Q2, 2022 Results on Aug 04, 2022